OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT
Rabah Redjoul, Anne Le Bouter, Vincent Parinet, et al.
The Lancet Haematology (2021) Vol. 8, Iss. 10, pp. e681-e683
Open Access | Times Cited: 74
Rabah Redjoul, Anne Le Bouter, Vincent Parinet, et al.
The Lancet Haematology (2021) Vol. 8, Iss. 10, pp. e681-e683
Open Access | Times Cited: 74
Showing 26-50 of 74 citing articles:
Interest of a third dose of BNT162b2 anti‐SARS‐CoV‐2 messenger RNA vaccine after allotransplant
Amandine Le Bourgeois, Marianne Coste‐Burel, Thierry Guillaume, et al.
British Journal of Haematology (2021) Vol. 196, Iss. 5
Open Access | Times Cited: 23
Amandine Le Bourgeois, Marianne Coste‐Burel, Thierry Guillaume, et al.
British Journal of Haematology (2021) Vol. 196, Iss. 5
Open Access | Times Cited: 23
Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell–Depleted Stem Cell Transplantation
Ok-Kyong Chaekal, Alexandra Gomez-Arteaga, Zhengming Chen, et al.
Transplantation and Cellular Therapy (2022) Vol. 28, Iss. 9, pp. 618.e1-618.e10
Open Access | Times Cited: 16
Ok-Kyong Chaekal, Alexandra Gomez-Arteaga, Zhengming Chen, et al.
Transplantation and Cellular Therapy (2022) Vol. 28, Iss. 9, pp. 618.e1-618.e10
Open Access | Times Cited: 16
A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Patients
Marika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1830-1830
Open Access | Times Cited: 16
Marika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1830-1830
Open Access | Times Cited: 16
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses
Elena Pettini, Annalisa Ciabattini, G Pastore, et al.
Blood Advances (2022) Vol. 6, Iss. 7, pp. 2247-2249
Open Access | Times Cited: 15
Elena Pettini, Annalisa Ciabattini, G Pastore, et al.
Blood Advances (2022) Vol. 6, Iss. 7, pp. 2247-2249
Open Access | Times Cited: 15
Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients
Mathieu Leclerc, Rabah Redjoul, Anne Le Bouter, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Mathieu Leclerc, Rabah Redjoul, Anne Le Bouter, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Allogeneic hematopoietic stem cell transplantation in the COVID-19 era
Jonathan Bordat, Sébastien Maury, Mathieu Leclerc
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Jonathan Bordat, Sébastien Maury, Mathieu Leclerc
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Immunologic responses to the third and fourth doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in cell therapy recipients: a systematic review and meta-analysis
Leyla Sharifi Aliabadi, Mojtaba Azari, Mohammad Reza Taherian, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Leyla Sharifi Aliabadi, Mojtaba Azari, Mohammad Reza Taherian, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Impact of donor vaccination on recipient response to early SARS-CoV-2 mRNA vaccination after allogeneic HSCT
Mathieu Leclerc, Rabah Redjoul, Anne Le Bouter, et al.
The Lancet Haematology (2022) Vol. 9, Iss. 5, pp. e318-e321
Open Access | Times Cited: 13
Mathieu Leclerc, Rabah Redjoul, Anne Le Bouter, et al.
The Lancet Haematology (2022) Vol. 9, Iss. 5, pp. e318-e321
Open Access | Times Cited: 13
An Exploration of COVID-19 Impact and Vaccine Hesitancy in Parents of Pediatric Hematopoietic Stem Cell Transplant (HCT) Recipients
Micah Skeens, Parishma Guttoo, Joseph Stanek, et al.
Bone Marrow Transplantation (2022) Vol. 57, Iss. 4, pp. 547-553
Open Access | Times Cited: 12
Micah Skeens, Parishma Guttoo, Joseph Stanek, et al.
Bone Marrow Transplantation (2022) Vol. 57, Iss. 4, pp. 547-553
Open Access | Times Cited: 12
Antibody response to mRNA SARS‐CoV‐2 vaccination in 182 patients after allogeneic hematopoietic cell transplantation
Astrid Beerlage, Karoline Leuzinger, Luca Valore, et al.
Transplant Infectious Disease (2022) Vol. 24, Iss. 3
Open Access | Times Cited: 12
Astrid Beerlage, Karoline Leuzinger, Luca Valore, et al.
Transplant Infectious Disease (2022) Vol. 24, Iss. 3
Open Access | Times Cited: 12
SARS-CoV-2 vaccine safety and immunogenicity in patients with hematologic malignancies, transplantation, and cellular therapies
Bin Ni, Ahmad Yanis, Kevin Dee, et al.
Blood Reviews (2022) Vol. 56, pp. 100984-100984
Open Access | Times Cited: 12
Bin Ni, Ahmad Yanis, Kevin Dee, et al.
Blood Reviews (2022) Vol. 56, pp. 100984-100984
Open Access | Times Cited: 12
Humoral and Cellular Response of Transplant Recipients to a Third Dose of mRNA SARS-CoV-2 Vaccine: A Systematic Review and Meta-analysis
Adrian Bailey, Harinad B. Maganti, Wei Cheng, et al.
Transplantation (2022) Vol. 107, Iss. 1, pp. 204-215
Open Access | Times Cited: 12
Adrian Bailey, Harinad B. Maganti, Wei Cheng, et al.
Transplantation (2022) Vol. 107, Iss. 1, pp. 204-215
Open Access | Times Cited: 12
Efficacy of SARS-CoV-2 Vaccine Doses in Allogeneic Hemopoietic Stem Cell Recipients: A Systematic Review and Meta-Analysis
Micah Rubin, Elizabeth Suelzer, Caden Ulschmid, et al.
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 2, pp. 393-399
Open Access | Times Cited: 2
Micah Rubin, Elizabeth Suelzer, Caden Ulschmid, et al.
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 2, pp. 393-399
Open Access | Times Cited: 2
Immunogenicity of a Third Dose of the BNT162b2 mRNA Covid-19 Vaccine in Patients with Impaired B Cell Reconstitution After Cellular Therapy—A Single Center Prospective Cohort Study
Ron Ram, Tal Freund, Tami Halperin, et al.
Transplantation and Cellular Therapy (2022) Vol. 28, Iss. 5, pp. 278.e1-278.e4
Open Access | Times Cited: 11
Ron Ram, Tal Freund, Tami Halperin, et al.
Transplantation and Cellular Therapy (2022) Vol. 28, Iss. 5, pp. 278.e1-278.e4
Open Access | Times Cited: 11
Third BNT162b2 mRNA SARS-CoV-2 Vaccine Dose Significantly Enhances Immunogenicity in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Israel Henig, Jonathan Isenberg, Dana Yehudai‐Ofir, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 775-775
Open Access | Times Cited: 6
Israel Henig, Jonathan Isenberg, Dana Yehudai‐Ofir, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 775-775
Open Access | Times Cited: 6
Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response—a prospective, single-arm study
Maryam Barkhordar, Bahram Chahardouli, Alireza Biglari, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Maryam Barkhordar, Bahram Chahardouli, Alireza Biglari, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients
Frédéric Baron, Lorenzo Canti, Kevin K. Ariën, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Frédéric Baron, Lorenzo Canti, Kevin K. Ariën, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Neutralizing antibody and T cell responses to SARS-CoV-2 vaccination in hematopoietic cell transplant recipients
Eleni Gavriilaki, Αναστασία Παπαδοπούλου, Tasoula Touloumenidou, et al.
Bone Marrow Transplantation (2022) Vol. 57, Iss. 7, pp. 1183-1186
Open Access | Times Cited: 10
Eleni Gavriilaki, Αναστασία Παπαδοπούλου, Tasoula Touloumenidou, et al.
Bone Marrow Transplantation (2022) Vol. 57, Iss. 7, pp. 1183-1186
Open Access | Times Cited: 10
Risk factors and characteristics influencing humoral response to COVID-19 vaccination in patients after allogeneic stem cell transplantation
Marie Luise Hütter‐Krönke, Adela Neagoie, Igor Wolfgang Blau, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Marie Luise Hütter‐Krönke, Adela Neagoie, Igor Wolfgang Blau, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Third BNT162b2 Vaccine Booster Dose against SARS-CoV-2-Induced Antibody Response among Healthcare Workers
Khetam Hussein, Halima Dabaja‐Younis, Moran Szwarcwort‐Cohen, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1741-1741
Open Access | Times Cited: 9
Khetam Hussein, Halima Dabaja‐Younis, Moran Szwarcwort‐Cohen, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1741-1741
Open Access | Times Cited: 9
A quick scoping review of the first year of vaccination against the COVID-19 pandemic: Do we need more shots or time?
Ayman El‐Menyar, Naushad Ahmad Khan, Ahammed Mekkodathil, et al.
Medicine (2022) Vol. 101, Iss. 37, pp. e30609-e30609
Open Access | Times Cited: 8
Ayman El‐Menyar, Naushad Ahmad Khan, Ahammed Mekkodathil, et al.
Medicine (2022) Vol. 101, Iss. 37, pp. e30609-e30609
Open Access | Times Cited: 8
Dissociated humoral and cellular immune responses after a three-dose schema of BNT162b2 vaccine in patients receiving anti-CD20 monoclonal antibody maintenance treatment for B-cell lymphomas
Sophie Candon, Véronique Lemee, Émilie Lévêque, et al.
Haematologica (2021) Vol. 107, Iss. 3, pp. 755-758
Open Access | Times Cited: 10
Sophie Candon, Véronique Lemee, Émilie Lévêque, et al.
Haematologica (2021) Vol. 107, Iss. 3, pp. 755-758
Open Access | Times Cited: 10
Cellular and Humoral Immunity after the Third Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplant Recipients
Laura Thümmler, Michael Koldehoff, Neslinur Fisenkci, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 972-972
Open Access | Times Cited: 7
Laura Thümmler, Michael Koldehoff, Neslinur Fisenkci, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 972-972
Open Access | Times Cited: 7
Humoral and cellular responses to SARS-CoV-2 BNT162b2 vaccination in allogeneic hematopoietic stem cell transplantation recipients
Alexis Cuffel, Sarah Maylin, Hélène Le Buanec, et al.
Vaccine (2022) Vol. 40, Iss. 33, pp. 4682-4685
Open Access | Times Cited: 6
Alexis Cuffel, Sarah Maylin, Hélène Le Buanec, et al.
Vaccine (2022) Vol. 40, Iss. 33, pp. 4682-4685
Open Access | Times Cited: 6
Third Early “Booster” Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses
Abdelhakim Ahmed–Belkacem, Rabah Redjoul, Rozenn Brillet, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1928-1928
Open Access | Times Cited: 6
Abdelhakim Ahmed–Belkacem, Rabah Redjoul, Rozenn Brillet, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1928-1928
Open Access | Times Cited: 6
